Ekramy E. Sayedahmed
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
-
- Influenza Virus Research Studies
- Respiratory viral infections research
Papers in
-
- Viral gastroenteritis research and epidemiology 11
- SARS-CoV-2 and COVID-19 Research 2
- Genetics 12
- Virus-based gene therapy research 12
- Co-authors
- Suresh K. Mittal (19 shared papers)Suryaprakash Sambhara (11 shared papers)Sai Vikram Vemula (2 shared papers)Rashmi Kumari (1 shared paper)Ian A. York (3 shared papers)Shivaprakash Gangappa (3 shared papers)Ahmed O. Hassan (3 shared papers)Rashmi Kumari (2 shared papers)
- Journals
- Vaccines (5 papers)Viruses (3 papers)npj Vaccines (1 paper)Clinical & Translational Immunology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- United StatesEgypt
In The Last Decade
Ekramy E. Sayedahmed
19 papers receiving 358 citations
Peers
Comparison fields: 5 of 55
- Infectious Diseases 159
- Epidemiology 172
- Genetics 110
- Immunology 79
- Animal Science and Zoology 34
Countries citing papers authored by Ekramy E. Sayedahmed
This map shows the geographic impact of Ekramy E. Sayedahmed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ekramy E. Sayedahmed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ekramy E. Sayedahmed more than expected).
Fields of papers citing papers by Ekramy E. Sayedahmed
This network shows the impact of papers produced by Ekramy E. Sayedahmed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ekramy E. Sayedahmed. The network helps show where Ekramy E. Sayedahmed may publish in the future.
Co-authors
The 25 scholars most cited alongside Ekramy E. Sayedahmed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 57 | |
| 2 | 2020 | 50 | |
| 3 | 2017 | 47 | |
| 4 | 2021 | 35 | |
| 5 | 2019 | 27 | |
| 6 | 2022 | 27 | |
| 7 | 2021 | 25 | |
| 8 | 2018 | 23 | |
| 9 | 2017 | 18 | |
| 10 | 2018 | 15 | |
| 11 | 2021 | 14 | |
| 12 | 2024 | 12 | |
| 13 | 2025 | 5 | |
| 14 | 2023 | 3 | |
| 15 | 2023 | 3 | |
| 16 | A potential approach for assessing the quality of human and nonhuman adenoviral vector preparations. | 2020 | 3 |
| 17 | 2025 | 2 | |
| 18 | 2025 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2025 | 0 |
About Ekramy E. Sayedahmed
Ekramy E. Sayedahmed is a scholar working on Infectious Diseases, Genetics, Epidemiology, Molecular Biology and Animal Science and Zoology, having authored 21 papers that have together received 368 indexed citations. Recurring topics across this work include Virus-based gene therapy research (12 papers), Viral gastroenteritis research and epidemiology (11 papers), Influenza Virus Research Studies (7 papers), Respiratory viral infections research (5 papers), Animal Virus Infections Studies (4 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), vaccines and immunoinformatics approaches (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Infectious Diseases (159 citations), Epidemiology (172 citations), Genetics (110 citations), Immunology (79 citations) and Animal Science and Zoology (34 citations). Ekramy E. Sayedahmed has collaborated with scholars based in United States and Egypt. Frequent co-authors include Suresh K. Mittal, Suryaprakash Sambhara, Sai Vikram Vemula, Rashmi Kumari, Ian A. York, Shivaprakash Gangappa, Ahmed O. Hassan, Rashmi Kumari, Chinnaswamy Jagannath and Vipul K. Singh. Their work appears in journals such as Vaccines, Viruses, npj Vaccines, Clinical & Translational Immunology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.